In vitro activities of the new antifungal drug eberconazole and three other topical agents against 200 strains of dermatophytes.
about
In vitro antifungal susceptibilities of Sporothrix schenckii in two growth phasesTranscriptional profiles of the response to ketoconazole and amphotericin B in Trichophyton rubrum.New therapeutic options for onychomycosis.Eberconazole 1% cream is an effective and safe alternative for dermatophytosis treatment: multicenter, randomized, double-blind, comparative trial with miconazole 2% cream.Investigational drugs for onychomycosis.Anti dermatophytic therapy--prospects for the discovery of new drugs from natural products.Critical review on retrospective and prospective changes in antifungal susceptibility testing for dermatophytes.In vitro susceptibility testing of dermatophytes isolated in Goiania, Brazil, against five antifungal agents by broth microdilution method.2-(benzylideneamino)phenol: a promising hydroxyaldimine with potent activity against dermatophytoses.Evaluation of disk diffusion method for determining eberconazole susceptibility of dermatophytes and influence of culture mediumIn-vitro Activity of 10 Antifungal Agents against 320 Dermatophyte Strains Using Microdilution Method in Tehran.Antifungal susceptibility and genotypical pattern of Microsporum canis strains.Antifungal susceptibility and genetic similarity of sequential isolates of Trichophyton rubrum from an immunocompetent patient with chronic dermatophytosis.In vitro susceptibility testing of dermatophytes isolated from pediatric cases in Nigeria against five antifungals.
P2860
Q24530443-2D16DE32-252F-4AEE-83B0-F7B9E0FFE0C3Q33261315-A89A6533-592D-44BB-B3AB-5B525743B455Q34245375-F2968C55-1F69-4850-A9A3-73C173515164Q34526041-074AF410-9462-4142-A099-299C082F7BEBQ38144164-7DB54C5E-3994-40E1-8D12-2E43A2042F43Q38201012-714D819C-1043-4F34-9BB8-3DDDBE0D4A25Q38862785-F7B60FAD-5D64-42B0-8817-339EB1E1A241Q38878593-ECFDF826-4264-4272-96BA-0CE8CCF8B411Q39074912-0FA42FA5-5C2A-4F32-9671-39F99E7CFB9FQ42727529-3645937E-DEF8-4EE7-9E6C-7CA66D3E698BQ42927428-0E89144B-1749-41B7-ABFB-A97C267B0E2FQ46668217-7ED5A43E-E633-4328-B267-B5BB3602044BQ46821424-2B9489CD-7A99-4771-9ABE-DA11C8952A5DQ46890845-66D0B9EA-54F3-44CF-883B-56A2A110415E
P2860
In vitro activities of the new antifungal drug eberconazole and three other topical agents against 200 strains of dermatophytes.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
In vitro activities of the new ...... 200 strains of dermatophytes.
@en
type
label
In vitro activities of the new ...... 200 strains of dermatophytes.
@en
prefLabel
In vitro activities of the new ...... 200 strains of dermatophytes.
@en
P2860
P1476
In vitro activities of the new ...... 200 strains of dermatophytes.
@en
P2093
Belkys Fernández-Torres
Isabel Inza
P2860
P304
P356
10.1128/JCM.41.11.5209-5211.2003
P407
P50
P577
2003-11-01T00:00:00Z